To reconstitute a standard 5 mg vial of Delta Sleep-Inducing Peptide (DSIP) for laboratory research, adding 1.0 mL to 2.5 mL of bacteriostatic water yields a manageable working concentration between 2.0 mg/mL and 5.0 mg/mL. Precision in volumetric diluent addition ensures accurate micro-dosing for in vitro assays and animal sleep architecture models.
To reconstitute a standard 5 mg vial of Delta Sleep-Inducing Peptide (DSIP) for laboratory research, adding 1.0 mL to 2.5 mL of bacteriostatic water yields a manageable working concentration between 2.0 mg/mL and 5.0 mg/mL. Precision in volumetric diluent addition ensures accurate micro-dosing for in vitro assays and animal sleep architecture models.
Determining how much bacteriostatic water for DSIP depends entirely on the target concentration ($C = m / V$) required by your experimental protocol. For a standard 5 mg DSIP 5mg vial, introducing 1.0 mL of reconstituting fluid creates a final concentration of 5.0 mg/mL (500 mcg per 0.1 mL). Adding 2.0 mL yields 2.5 mg/mL (250 mcg per 0.1 mL), while 2.5 mL creates a concentration of 2.0 mg/mL (200 mcg per 0.1 mL).
Because lyophilized DSIP is highly soluble in aqueous media, larger volumes such as 5.0 mL can also be utilized to produce lower working concentrations (1.0 mg/mL). Lower concentrations facilitate high volumetric accuracy when dispensing micro-liter quantities in automated microplate readers or small animal injection setups. For quick calculations across varying mass and diluent parameters, researchers frequently utilize our interactive peptide reconstitution calculator.
The following matrix outlines the final liquid concentration when reconstituting a standard 5 mg lyophilized DSIP vial with various volumes of 0.9% benzyl alcohol bacteriostatic water. Selecting the correct reconstitution volume allows researchers to align target microgram quantities with standard laboratory syringe calibrations (e.g., U-100 insulin syringes or micropipettes).
For a 5.0 mg DSIP Vial: • 1.0 mL Diluent Volume = 5.0 mg/mL (500 mcg per 0.1 mL / 50 mcg per 0.01 mL) • 2.0 mL Diluent Volume = 2.5 mg/mL (250 mcg per 0.1 mL / 25 mcg per 0.01 mL) • 2.5 mL Diluent Volume = 2.0 mg/mL (200 mcg per 0.1 mL / 20 mcg per 0.01 mL) • 3.0 mL Diluent Volume = 1.67 mg/mL (167 mcg per 0.1 mL / 16.7 mcg per 0.01 mL) • 5.0 mL Diluent Volume = 1.0 mg/mL (100 mcg per 0.1 mL / 10 mcg per 0.01 mL)
When planning assays requiring high precision, adjusting diluent volumes allows researchers to minimize measurement error. If an assay requires 100 mcg per administration, a 2.5 mL diluent volume allows dispensing exactly 0.05 mL, reducing volumetric margin of error compared to attempting to pipette 0.02 mL from a highly concentrated 1.0 mL mixture.
Calculating peptide concentration relies on fundamental volumetric arithmetic: Concentration ($C$) = Mass ($m$) / Volume ($V$). When working with a 5 mg DSIP mass, converting milligrams to micrograms ($5\text{ mg} = 5,000\text{ mcg}$) simplifies working calculations for micro-scale preclinical assays.
For example, to calculate the microgram content per unit on a standard U-100 syringe (where 100 units = 1.0 mL, meaning 1 unit = 0.01 mL): 1. Divide total mass by total reconstituted volume: $5,000\text{ mcg} / 2.0\text{ mL} = 2,500\text{ mcg/mL}$. 2. Divide concentration per mL by 100 units: $2,500\text{ mcg/mL} / 100\text{ units} = 25\text{ mcg per unit}$.
Using this mathematical model, laboratory investigators can rapidly adjust their diluent additions to suit the volumetric constraints of their testing apparatus, whether using high-precision micropipettes or automated fluid handlers across our full catalog of research peptides.
Delta Sleep-Inducing Peptide (DSIP) is an amphiphilic nonapeptide with the primary amino acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. With a molecular weight of approximately 848.81 g/mol, DSIP possesses a balanced distribution of hydrophobic (Trp, Ala) and charged/polar residues (Asp, Ser, Glu).
Preclinical studies suggest that this primary sequence imparts high solubility in neutral and slightly acidic aqueous solutions. In laboratory trials investigating delta-wave (deep) sleep induction, stress-axis modulation, and recovery during rest, DSIP exhibits minimal aggregation when reconstituted in sterile bacteriostatic water containing 0.9% benzyl alcohol as a preservative.
Because DSIP lacks extensive secondary structure formation in free solution, it readily dissolves without requiring aggressive agitation or chemical co-solvents, making it a stable subject for central nervous system and neuroendocrine in vitro models.
To preserve peptide integrity and prevent chemical degradation, researchers should follow rigorous aseptic laboratory protocols during reconstitution:
1. Disinfect the rubber stopper of the lyophilized DSIP vial and the bacteriostatic water vial using 70% isopropyl alcohol swabs in a laminar flow hood. 2. Draw the exact required volume of bacteriostatic water using a sterile syringe. 3. Insert the needle through the stopper of the DSIP vial at a slight angle. Because sealed vials contain a partial vacuum, allow the vacuum to pull the diluent slowly into the vial, directing the fluid stream down the inner glass wall rather than directly onto the lyophilized cake. 4. Once diluent transfer is complete, gently equalize vial pressure if necessary by drawing back an equivalent volume of air into the syringe before withdrawing the needle. 5. Gently swirl the vial in a circular motion until the cake completely dissolves into a clear, colorless solution. Never shake or vortex peptide solutions, as mechanical shear forces can cause physical denaturation or peptide aggregation.
Once reconstituted with bacteriostatic water, DSIP remains stable at refrigerated temperatures (2°C to 8°C) for up to 28 days due to the bacteriostatic action of 0.9% benzyl alcohol. However, for long-term storage across multi-week animal studies or cell culture series, sub-aliquoting is strongly recommended.
Dividing the reconstituted solution into single-use polypropylene micro-centrifuge tubes prevents repeated freeze-thaw cycles, which can fragment peptide chains and reduce functional yield. Aliquots stored at -20°C to -80°C maintain structural stability for up to 12 months. Upon thawing an aliquot for assay preparation, any unused portion should be stored at 4°C and used within several days rather than refrozen.
In neurochemical and circadian rhythm research, DSIP is often evaluated alongside other central-acting research compounds. Comparative preclinical studies evaluate how different peptide structures target distinct regulatory pathways within the central nervous system.
While DSIP is primary researched for delta-wave (deep) sleep induction and hypothalamic-pituitary-adrenal (HPA) stress-axis modulation, Epitalon is primarily studied in cellular aging models for its interaction with telomerase activity and pineal gland regulation. Meanwhile, Selank, a synthetic derivative of tuftsin, is evaluated for anxiolytic activity and neurotrophin modulation without displaying direct sedating effects on sleep architecture. Researchers investigating recovery kinetics and physiological homeostasis often compare these regulatory peptides in concurrent in vitro bioassays.
Ensuring consistent concentration and accurate reconstitution requires high-purity raw material free from structural isomers or lyophilisates breakdown products. PX1 Research subjects every lot of DSIP to rigorous analytical verification, including High-Performance Liquid Chromatography (HPLC) to confirm structural purity exceeding 98% and Mass Spectrometry (MS) to verify precise molecular identity.
Furthermore, every batch undergoes endotoxin testing to guarantee compatibility with delicate cell cultures and animal models. All analytical data is documented on our lot-specific certificate of analysis (COA), providing full transparency for academic and industrial research facilities. For labs planning bulk assay series, customized supply programs are accessible through our wholesale lab ordering portal.
In preclinical rodent models monitoring electroencephalographic (EEG) activity, DSIP administration is observed for its capacity to promote slow-wave (delta) sleep patterns and alter plasma corticosteroid kinetics during rest. To avoid confounding physiological responses, vehicle controls must be carefully matched.
When performing electrophysiological or receptor-binding studies, researchers should verify that the final concentration of benzyl alcohol from the bacteriostatic water does not interfere with cellular viability or ion channel kinetics. In sensitive micro-perfusion setups or intracranial administration models, reconstituting DSIP in sterile non-preserved 0.9% sodium chloride or phosphate-buffered saline (PBS) immediately prior to application is preferred over bacteriostatic water to eliminate preservative effects.
How much bacteriostatic water should I add to a 5mg DSIP vial?
Adding 1.0 mL to 2.5 mL of bacteriostatic water to a 5 mg DSIP vial is standard. Adding 2.0 mL yields a final concentration of 2.5 mg/mL (250 mcg per 0.1 mL), which allows for flexible, precise micropipetting in research assays.
What is DSIP primary researched for in laboratory settings?
DSIP (Delta Sleep-Inducing Peptide) is studied primarily for delta-wave (deep) sleep induction, neuroendocrine regulation, stress-axis (HPA) modulation, and physiological recovery kinetics during rest in preclinical models.
Can I use sterile water instead of bacteriostatic water for DSIP?
Sterile water can be used if the reconstituted solution will be used immediately in a single assay. However, bacteriostatic water containing 0.9% benzyl alcohol is required if the vial will be stored and reused over multiple days, as it inhibits microbial growth.
How long does reconstituted DSIP last in storage?
When reconstituted with bacteriostatic water, DSIP remains stable for up to 28 days when refrigerated at 2°C to 8°C. For long-term storage up to 12 months, aliquoted samples should be frozen at -20°C or -80°C.
Why should DSIP not be shaken during reconstitution?
Shaking creates mechanical shear forces that can denature the nonapeptide structure or cause hydrophobic aggregation. Gentle swirling ensures complete dissolution without damaging the compound.
Where can I find the Certificate of Analysis (COA) for PX1 Research DSIP?
Every lot of DSIP manufactured by PX1 Research includes a batch-specific COA available on our website under the COA verification page, confirming HPLC purity, MS identity, and endotoxin compliance.
What compounds are comparable to DSIP in regulatory peptide research?
DSIP is frequently compared in preclinical literature with Epitalon (studied for pineal gland and circadian rhythm modulation) and Selank (studied for CNS stress responses and neuroprotective signaling).
Does PX1 Research ship peptides directly from USA facilities?
Yes. All PX1 Research compounds are USA-manufactured and dispatched directly from our California and Arizona fulfillment centers with same-day shipping on orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.